Metabolic correlates of clinical heterogeneity in questionable Alzheimer's disease
- 31 December 2008
- journal article
- research article
- Published by Elsevier in Neurobiology of Aging
- Vol. 29 (12) , 1823-1829
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Heterogeneity of Brain Glucose Metabolism in Mild Cognitive Impairment and Clinical Progression to Alzheimer DiseaseArchives of Neurology, 2005
- FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairmentNeurocase, 2005
- Cognitive impairment in preclinical Alzheimer's disease: A meta-analysis.Neuropsychology, 2005
- Brain perfusion correlates of the apathy inventory dimensions of Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 2004
- Mild cognitive impairmentNeurology, 2003
- The neural substrates of episodic memory impairment in Alzheimer’s disease as revealed by FDG–PET: relationship to degree of deteriorationBrain, 2002
- Prediction of cognitive decline in normal elderly subjects with 2-[ 18 F]fluoro-2-deoxy- d -glucose/positron-emission tomography (FDG/PET)Proceedings of the National Academy of Sciences, 2001
- Hippocampal formation glucose metabolism and volume losses in MCI and ADNeurobiology of Aging, 2001
- Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairmentNeuroReport, 2001
- The Neuropsychiatric InventoryNeurology, 1994